GOVIN HOLDINGS - HOME

govinholdings.com

GO-VIN HOLDINGS, SINGAPORE ADVISES AMNEAL PHARMACEUTICALS IN ACQUISITION OF INDIAN ONCOLOGY INJECTABLES PHARMACEUTICALC COMPANY Corporate team advises seventh largest generics firm in acquisition of an Oncology Injectable Manufacturing Company in India 03 December 2014 Go-Vin Holdings Singapore advised Amneal Pharmaceuticals LLC – the seventh largest generic pharmaceutical company in the U.S. – in the acquisition of all shares in Epsilon Pharmaceuticals, Hyderabad, India, which has state-of-the art manufacturing company for generic medicinal products in Oncology for the global pharmaceutical market. Amneal Pharmaceuticals LLC, headquartered in Bridgewater, New Jersey, develops, manufactures and distributes generic pharmaceutical products and is currently the seventh largest U.S. generics manufacturer in number of prescriptions. It is one of the fastest growing generic pharmaceutical companies and is expanding internationally with global operations in Switzerland, UK, Ireland, India, Spain, Denmark, Germany and Australia. The Go-Vin Holdings corporate team was led by Mr Anand Govindaluri and responsible for the strategy, term-sheet negotiation, technical and commercial due-diligence and structuring the investment agreements along with its associates Ernst & Young (India) and AZB& Partners (India).